+1 (319) 433-6210 contact@medicaldevicesandpharma.com
Medical Devices and Pharma
  • Home
  • Consumer
    • Consumer News
    • Food and Beverage
    • Supplements
    • Cosmetics
  • Quality
    • Quality
    • QSR-to-QMSR
    • Internal Audit
  • Regulatory
    • Regulatory Services
    • Regulatory Talent
    • Medical Devices
    • Pharma
    • Biologics
    • Combination Products
    • Veterinary
  • Career
    • Education
  • News
    • Latest
    • Alerts
  • Contact
Select Page

Tisotumab Vedotin-tftv for Recurrent or Metastatic Cervical Cancer 

by Devices and Pharma | May 3, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

Drug Innovation - Tisotumab vedotin-tftv, marketed as Tivdak For Recurrent or Metastatic Cervical Cancer Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact Product Approval for Cervical Cancer Drug   Exciting...

FDA Approves Anktiva for Bladder Cancer 

by Devices and Pharma | May 3, 2024 | Consumer Information, FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

FDA Drug Innovation - Anktiva Treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact New Drug Approval  In a significant development for...

FDA Approves Versatile Antibiotic Zevtera for Three Key Infections 

by Devices and Pharma | Apr 3, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

FDA Approves New Antibiotic for Three Different Uses Zevtera effective against three bacterial infections Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact FDA...

FDA Approves Treatment for Platinum-Resistant Ovarian Cancer 

by Devices and Pharma | Mar 31, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

New Treatment for Platinum-Resistant Ovarian Cancer Mirvetuximab Soravtansine-Gynx (Elahere) Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact In a significant...

FDA Approves Lamzede for Treatment of Alpha-mannosidosis

by David McConkey | Mar 19, 2023 | FDA Approvals, FDA Public Information, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact The U.S. Food and Drug Administration (FDA) on February 17, 2023 announced the approval the first-ever enzyme...

FDA Approves Rukabia for HIV Treatment

by David McConkey | Mar 16, 2023 | FDA Approvals, FDA Public Information, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact The U.S. Food and Drug Administration (FDA) on December 22, 2022 announced the approval of a new HIV drug called...
« Older Entries
Next Entries »

QMSR

Regulatory

Quality

Consumer

MDP Facebook page

Consumer

Devices

Pharma

Veterinary

LinkedIn logo